Innovation and competition in advanced therapy medicinal products

Innovation and competition in advanced therapy medicinal products

Graphical Abstract Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics mark...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EMBO molecular medicine 2019-03, Vol.11 (3), p.1-n/a
Hauptverfasser: Seoane‐Vazquez, Enrique, Shukla, Vaishali, Rodriguez‐Monguio, Rosa
Format: Artikel
Sprache:eng
Schlagworte:
Biological products
Biological Therapy - methods
Blood banks
Blood products
Cell- and Tissue-Based Therapy
Collagen
Competition
Drug therapy
Efficient markets
EMBO16
EMBO39
FDA approval
Gene therapy
Genetic engineering
Genetic Therapy
Humans
Innovations
Manufacturers
Market entry
Medical device industry
Medical equipment
Opinion
Patients
Prices
Proteins
Regulatory agencies
Tissue Engineering
United States
United States Food and Drug Administration
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Graphical Abstract Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics market.
ISSN:1757-4676
1757-4684
DOI:10.15252/emmm.201809992